Showing results (311-320 of 713) with videos related to
Sort By:
Pageof 72
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|May 1, 1991
[Osteoarticular complications after hepatic transplantation]J Taillandier, M Alemanni, D SamuelJournal of Wildlife Diseases|April 1, 1991
Brain acetylcholinesterase activity in botulism-intoxicated mallardsT E Rocke, M D SamuelAmerican Journal of Clinical Oncology|March 10, 2001
Prospective phase II trial of iriontecan, 5-fluorouracil, and leucovorin in combination as salvage therapy for advanced colorectal cancerM A Gil-Delgado, F Guinet, D Castaing, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
FK 506 primary immunosuppression following emergency liver transplantation for fulminant hepatic failure. European FK 506 Study Liver GroupJ Devlin, P Wong, R Williams, et al.Journal De Chirurgie|August 1, 1989
[Cyclosporin, toxicity and efficacy in rejection of liver allografts in the rat]A Settaf, J Gugenheim, M K Lahlou, et al.European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|January 1, 1985
Effects of hyperthermia on normal or neoplastic rat liverR Adam, L Poggi, D Houssin, et al.Transplantation|February 1, 1988
Relationship between the liver and lymphocytotoxic alloantibodies in inbred rats. Specific absorption by nonparenchymal liver cellsJ Gugenheim, B Le Thai, P Rouger, et al.The Journal of Infusional Chemotherapy|January 1, 1995
A phase I-II trial of five-day continuous intravenous infusion of 5-fluorouracil delivered at circadian rhythm modulated rate in patients with metastatic colorectal cancerF Lévi, A Soussan, R Adam, et al.Gastroenterology|August 28, 1999
European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) GroupC Féray, L Caccamo, G J Alexander, et al.Immunopharmacology and Immunotoxicology|March 1, 1993
In vitro and in vivo comparative studies on immunosuppressive properties of cyclosporines A, C, D and metabolites M1, M17 and M21N Sadeg, C Pham-Huy, P Rucay, et al.Pageof 72